Because<unk>  is caused by a gene mutation or deletion, there is no "cure." One of the aims of treatment is to reduce scaling by removing the excess, flaky scales, and keep the skin hydrated. This can be achieved using a variety of topical creams. Other treatments involve * Keratolytic agents such as Ammonium lactate (Lac-Hydrin) are used to facilitate the release of retained corneocytes. * oral isotretinoin * acitretin * The topical receptor-selective retinoid tazarotene Research is ongoing with regard to the use of gene therapy to treat<unk> . Timber Pharmaceuticals is planning on conducting a phase 3 trial of its investigational topical isotretinoin product in the second quarter of 2022 for the treatment of congential<unk> .
X-linked ichthyosis
Keratoderma
Poikiloderma
Dyskeratosis congenita
Halogenoderma
Photodermatosis
Chyloderma
Bromoderma